• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Agents Chemother. Comparative population analysis of Klebsiella pneumoniae with extended-spectrum β-lactamases colonizing patients in rehab

Giuseppe

Emeritus
[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]

Comparative population analysis of Klebsiella pneumoniae with extended-spectrum β-lactamases colonizing patients in rehabilitation centers in four countries


A. Baraniak 1, R. Izdebski 1, J. Fiett 1, E. Sadowy 1, A. Adler 2, M. Kazma 2, J. Salomon 3, C. Lawrence 4, A. Rossini 5, A. Salvia 5, J. Vidal Samso 6, J. Fierro 6, M. Paul 7, Y. Lerman 8, S. Malhotra-Kumar 9, C. Lammens 9, H. Goossens 9, W. Hryniewicz 1, C. Brun-Buisson 10, Y. Carmeli 2 and M. Gniadkowski 1,* on behalf of the MOSAR WP2 & WP5 study groups

Author Affiliations: <SUP>1</SUP>National Medicines Institute, Warsaw, Poland <SUP>2</SUP>Division of Epidemiology and Preventive Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel <SUP>3</SUP>INSERM, MSRSS, Cnam, Paris, France <SUP>4</SUP>Groupe Hospitalier Universitaire Paris Ile-de-France Ouest, France <SUP>5</SUP>Fondazione Santa Lucia IRCCS, Rome, Italy <SUP>6</SUP>Institute Guttmann, Barcelona, Spain <SUP>7</SUP>Loewenstein Hospital, Ra?anana, Israel <SUP>8</SUP>Geriatric Division, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel <SUP></SUP>University of Antwerp, Antwerp, Belgium <SUP>10</SUP>INSERM, U957 & Universit? Paris-Est, Cr?teil, France



ABSTRACT

The international project MOSAR was conducted in five rehabilitation centers; patients were screened for rectal carriage of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. Among 229 Klebsiella pneumoniae isolates four clonal groups (CG) or complexes (CC) prevailed: CG17 in France, CG101 in Italy, CG15 in Spain, and CC147 in Israel. ESBLs, mainly CTX-Ms, were produced by 226 isolates; three isolates expressed AmpC-like cephalosporinases. High genetic diversity of K. pneumoniae populations was observed, with specific characteristics at each center.



FOOTNOTES

* Corresponding author: Marek Gniadkowski, National Medicines Institute, ul. Chełmska 30/34, 00-725 Warsaw, Poland. Fax: (+48) 22 - 841 29 49. E-mail: gniadkow@cls.edu.pl

Copyright ? 2013, American Society for Microbiology. All Rights Reserved.
-
------
 
Back
Top Bottom